InvestorsHub Logo
Followers 11
Posts 1516
Boards Moderated 0
Alias Born 10/20/2014

Re: mas post# 18269

Saturday, 11/15/2014 11:28:22 AM

Saturday, November 15, 2014 11:28:22 AM

Post# of 47873
MS- first off, that document appeared before there was a sale or an IDIQ. Secondly, ceo Bolduc has answered the question in 2 ways- one, the document was NOT reflective of the IDIQ price accepted by tsa, further, when questioned about B-220 vs H-150 prices he specifically said the B-220 sells for a much higher price than the H-150, which follows pattern and he wasn't referring to an MSRP price. I think the 150 ranges from 18-25K and 220 ranges from 35K-bid low end to 45K MSRP.
Additionally, the company was fairly cognizant of the pricing scheme submitted by Smiths and certainly by Morpho as Dr. Jones likely looked at both price schemes, one from the inside and one from the outside. I believe Smith's underbid Morpho last time around.

You can figure 1100 units at low end of 35K and high end of 37K, add expendibles-service etc at 15% of list not net. This was a 40 to 46M dollar piece of the IDIQ.

Many folks here have overlooked Dr. Jones role in this entire deal. He's sharp, has done it at a competitor and never walks into a gunfight with a fork. The man knows the way of the tsa.

Investors are NOT buying F. U. D. when we have a ceo we trust and I trust ceo Bolduc. As far as your post about the India / H150 order, try to remember, ceo Bolduc made those statements at the time that he took as WORD from the Indian Gov., which later Smith's protest turned upside down, delayed and deleveraged the entire deal. And one telling detail, caused share price decay for a period of time.

So to accuse our ceo of lying to shareholders, well that is a pretty damaging statement.
As far as I can see, the damage is done to YOU, not ceo Bolduc nor this company.

Best of Better LUCK to ALL IMSC LONGS!

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.